Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by
BRCA1/2
mutation status for platinum-sensitive relapsed ovarian cancer
Li-Jen Cheng & Mohamed Ismail Abdul Aziz
· 2021-03-08
Links
DOI
PubMed
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Institutions
Ministry Of Health
Ministry Of Health Httpsrororg00mrhvv69
Authors
Li-Jen Cheng
,
Mohamed Ismail Abdul Aziz